Methotrexate Treatment of Rheumatic Diseases: Can We Do Better?

被引：7

作者：

Kremer, Joel M. ^{[1
]}

机构：

[1] Albany Med Coll, Albany, NY 12206 USA

来源：

ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 11期

关键词：

D O I：

10.1002/art.24032

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：3279 / 3282

页数：4

共 22 条

[1]

EFFICACY AND SAFETY OF 10-DEAZAAMINOPTERIN IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - A ONE-YEAR CONTINUATION, DOUBLE-BLIND-STUDY [J].

ALARCON, GS ;

CASTANEDA, O ;

FERRANDIZ, M ;

KRUMDIECK, CL ;

KOOPMAN, WJ .

ARTHRITIS AND RHEUMATISM, 1992, 35 (11) :1318-1321

[2]

Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis [J].

Baggott, JE ;

Bridges, SL ;

Morgan, SL .

ARTHRITIS AND RHEUMATISM, 2005, 52 (01) :356-358

[3]

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis [J].

Braun, J. ;

Kaestner, P. ;

Flaxenberg, P. ;

Waehrisch, J. ;

Hanke, P. ;

Demary, W. ;

von Hinueber, U. ;

Rockwitz, K. ;

Heitz, W. ;

Pichlmeier, U. ;

Guimbal-Schmolck, C. ;

Brandt, A. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (01) :73-81

[4]

The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

[5]

Phase II trial of oral aminopterin for adults and children with refractory acute leukemia [J].

Cole, PD ;

Drachtman, RA ;

Smith, AK ;

Cate, S ;

Larson, RA ;

Hawkins, DS ;

Holcenberg, J ;

Kelly, K ;

Kamen, BA .

CLINICAL CANCER RESEARCH, 2005, 11 (22) :8089-8096

[6]

Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia [J].

Cole, Peter D. ;

Drachtman, Richard A. ;

Masterson, Margaret ;

Smith, Angela K. ;

Glod, John ;

Zebala, John A. ;

Lisi, Stacey ;

Drapala, Drew-Anne ;

Kamen, Barton A. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) :65-75

[7]

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) [J].

Combe, B. ;

Landewe, R. ;

Lukas, C. ;

Bolosiu, H. D. ;

Breedveld, F. ;

Dougados, M. ;

Emery, P. ;

Ferraccioli, G. ;

Hazes, J. M. W. ;

Klareskog, L. ;

Machold, K. ;

Martin-Mola, E. ;

Nielsen, H. ;

Silman, A. ;

Smolen, J. ;

Yazici, H. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (01) :34-45

[8]

Pharmacokinetics of Oral Methotrexate in Patients With Rheumatoid Arthritis [J].

Dalrymple, Judith M. ;

Stamp, Lisa K. ;

O'Donnell, John L. ;

Chapman, Peter T. ;

Zhang, Mei ;

Barclay, Murray L. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (11) :3299-3308

[9]

Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis [J].

Dervieux, T ;

Furst, D ;

Lein, DO ;

Capps, R ;

Smith, K ;

Walsh, M ;

Kremer, J .

ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2766-2774

[10]

Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis [J].

Dervieux, Thierry ;

Greenstein, Neal ;

Kremer, Joel .

ARTHRITIS AND RHEUMATISM, 2006, 54 (10) :3095-3103

← 1 2 3 →